Next Up, Parkinson's: Coalition Against Major Diseases Moves To Link Neurodegenerative Ailments In Database
This article was originally published in The Pink Sheet Daily
Executive Summary
Following the creation of an Alzheimer's disease database, firms will submit control trial data help develop Parkinson's and Huntington's biomarkers as well.
You may also be interested in...
Woodcock's Legacy: CDER Organizational Improvements
In interview with the Pink Sheet, Center for Drug Evaluation and Research director discusses her 30-year career, retirement speculation, and upcoming projects.
BIO Looking For Clinical Trial Reform Priorities
Trade organization may put its lobbying muscle behind ideas intended to lower trial costs and raise efficiency.
TB Regimen Could Pave Way For More FDA Involvement In Neglected Tropical Diseases
TB Alliance plans to seek FDA approval for its treatment regimen, which is beginning a Phase IIb trial, as the agency looks to respond to calls for a clearer and quicker pathway for NTD drugs.